5Bower SL. Muhiple primary bronchogenic carcinomas of the lung. Am J Roentgenol, 1983,140:253-258.
6Reedijk M, Hodgson N, Gohla G, et al. A prospective study of tumor and technical factors associated with positive margins in breast-conservation therapy for nonpalpable malignancy[J]. Am J Surg,2012,204(3) :263-268.
7Solin LJ, Gray R, Goldstein LJ, et al. Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recur- rence after breast conservation treatment with radiation for early stage breast carcinoma : results from the Eastern Cooperative On- cology Group E2197 study[J]. Breast Cancer Res Treat, 2012, 134(2) :683-692.
10Clemons M, Gelmon KA, Pritchard KI, et al. Bone-targeted a- gents and skeletal-related events in breast cancer patients with- bone metastases:the state of the art[J]. Curt Oncol, 2012, 19 (5) :259-268.
